• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Protalix BioTherapeutics, Inc. (PLX)

    -NYSE MKT
    1.95 Down 0.03(1.52%) Dec 19, 4:01PM EST
    Add to Portfolio
    Prev Close:1.98
    Open:1.96
    Bid:1.97 x 400
    Ask:2.11 x 300
    1y Target Est:2.00
    Beta:0.24
    Earnings Date:Mar 12 - Mar 19 (Est.)
    Day's Range:1.92 - 1.99
    52wk Range:1.86 - 5.30
    Volume:87,524
    Avg Vol (3m):367,386
    Market Cap:181.29M
    P/E (ttm):N/A
    EPS (ttm):-0.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PLX

    Comparison

    Symbol% ChgMkt Cap
    PLXDown 1.52%181.29M
    SHPGDown 1.88%42.45B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.36
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.27
    Quarterly EPS Est (Dec-14) :-0.04
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):-0.29

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Protalix BioTherapeutics, Inc., a biopharmaceutical company, together with its subsidiary, Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression sy... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback